72 related articles for article (PubMed ID: 224075)
1. Adrenocorticotropin-dependent virilizing paraovarian tumors in Nelson's syndrome.
Baranetsky NG; Zipser RD; Goebelsmann U; Kurman RJ; March CM; Morimoto I; Stanczyk FZ
J Clin Endocrinol Metab; 1979 Sep; 49(3):381-6. PubMed ID: 224075
[TBL] [Abstract][Full Text] [Related]
2. Virilizing paraovarian tumors: a consequence of Nelson's syndrome?
Wild RA; Albert RD; Zaino RJ; Abrams CS
Obstet Gynecol; 1988 Jun; 71(6 Pt 2):1053-6. PubMed ID: 3374920
[TBL] [Abstract][Full Text] [Related]
3. Cortisol and androgen secretion in a case of Nelson's syndrome with paratesticular tumors: response to cyproheptadine therapy.
Krieger DT; Samojlik E; Bardin CW
J Clin Endocrinol Metab; 1978 Oct; 47(4):837-44. PubMed ID: 233683
[TBL] [Abstract][Full Text] [Related]
4. Corticotropin-releasing hormone (CRH) stimulation in Nelson's syndrome: response of adrenocorticotropin secretion to pulse injection and continuous infusion of CRH.
Oldfield EH; Schulte HM; Chrousos GP; Gold PW; Benker G; Peterson RE; Cutler GB; Loriaux DL
J Clin Endocrinol Metab; 1986 May; 62(5):1020-6. PubMed ID: 3007552
[TBL] [Abstract][Full Text] [Related]
5. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
[TBL] [Abstract][Full Text] [Related]
6. ACTH secretory responsiveness of pituitary adrenotroph cell tumor to adrenocorticotropin-releasing factor in Cushing's disease and Nelson's syndrome.
Takeda R; Ito T; Kawato M; Nakabayashi H; Miyamori I; Morise T; Koshida H; Ikeda M
Exp Clin Endocrinol; 1986 Jun; 87(1):31-7. PubMed ID: 3017732
[TBL] [Abstract][Full Text] [Related]
7. The evaluation of sodium valproate in the treatment of Nelson's syndrome.
Dornhorst A; Jenkins JS; Lamberts SW; Abraham RR; Wynn V; Beckford U; Gillham B; Jones MT
J Clin Endocrinol Metab; 1983 May; 56(5):985-91. PubMed ID: 6300181
[TBL] [Abstract][Full Text] [Related]
8. Activation of virilizing adrenal rest tissues by excessive ACTH production. An unusual presentation of Nelson's syndrome.
Verdonk C; Guerin C; Lufkin E; Hodgson SF
Am J Med; 1982 Sep; 73(3):455-9. PubMed ID: 7124773
[TBL] [Abstract][Full Text] [Related]
9. Paratesticular tumours in a patient with Nelson's syndrome.
Ntalles K; Kostoglou-Athanassiou I; Georgiou E; Ikkos D
Horm Res; 1996; 45(6):291-4. PubMed ID: 8793524
[TBL] [Abstract][Full Text] [Related]
10. Two unusual variants of Nelson's syndrome.
Bonner RA; Mukai K; Oppenheimer JH
J Clin Endocrinol Metab; 1979 Jul; 49(1):23-9. PubMed ID: 221528
[No Abstract] [Full Text] [Related]
11. Hyperprolactinemia in Cushing's disease and Nelson's syndrome.
Yamaji T; Ishibashi M; Teramoto A; Fukushima T
J Clin Endocrinol Metab; 1984 May; 58(5):790-5. PubMed ID: 6323516
[TBL] [Abstract][Full Text] [Related]
12. Sustained improvements in plasma ACTH and clinical status in a patient with Nelson's syndrome treated with pasireotide LAR, a multireceptor somatostatin analog.
Katznelson L
J Clin Endocrinol Metab; 2013 May; 98(5):1803-7. PubMed ID: 23539733
[TBL] [Abstract][Full Text] [Related]
13. Ovarian adrenal rest tumor in a congenital adrenal hyperplasia patient with adrenocorticotropin hypersecretion following adrenalectomy.
Tiosano D; Vlodavsky E; Filmar S; Weiner Z; Goldsher D; Bar-Shalom R
Horm Res Paediatr; 2010; 74(3):223-8. PubMed ID: 20431278
[TBL] [Abstract][Full Text] [Related]
14. ACTH responses to somatostatin, valproic acid and dexamethasone in Nelson's syndrome.
Kasperlik-Załuska AA; Zgliczyński W; Jeske W; Zdunowski P
Neuro Endocrinol Lett; 2005 Dec; 26(6):709-12. PubMed ID: 16380696
[TBL] [Abstract][Full Text] [Related]
15. Bilateral testicular tumors in congenital adrenal hyperplasia.
Kirkland RT; Kirkland JL; Keenan BS; Bongiovanni AM; Rosenberg HS; Clayton GW
J Clin Endocrinol Metab; 1977 Feb; 44(2):369-78. PubMed ID: 190255
[TBL] [Abstract][Full Text] [Related]
16. A met-enkephalin analog inhibits adrenocorticotropin secretion by cultured pituitary cells from a patient with Nelson's syndrome.
Lamberts SW; Oosterom R; Verleun T; Bons EG; Uitterlinden P
J Clin Endocrinol Metab; 1981 Nov; 53(5):1084-6. PubMed ID: 6270182
[TBL] [Abstract][Full Text] [Related]
17. Nelson's syndrome: case report and review of the literature.
Ullrich I; Lizarralde G
South Med J; 1977 Dec; 70(12):1444-6. PubMed ID: 202034
[TBL] [Abstract][Full Text] [Related]
18. No effect of the PPAR-gamma agonist rosiglitazone on ACTH or cortisol secretion in Nelson's syndrome and Cushing's disease in vitro and in vivo.
Kreutzer J; Jeske I; Hofmann B; Blumcke I; Fahlbusch R; Buchfelder M; Buslei R
Clin Neuropathol; 2009; 28(6):430-9. PubMed ID: 19919817
[TBL] [Abstract][Full Text] [Related]
19. Nelson's syndrome and spontaneous pituitary tumor infarction.
Jordan RM; Cook DM; Kendall JW; Kerber CW
Arch Intern Med; 1979 Mar; 139(3):340-2. PubMed ID: 426579
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of bromocriptine, cyproheptadine, and valproic acid on plasma adrenocorticotropin secretion in Nelson's syndrome.
Mercado-Asis LB; Yanovski JA; Tracer HL; Chik CL; Cutler GB
J Clin Endocrinol Metab; 1997 Feb; 82(2):514-7. PubMed ID: 9024246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
